Skip to main content

Want a detailed portfolio tracker?

LB Pharmaceuticals (LBRX) P/E (2025 - 2026)

LB Pharmaceuticals (LBRX) P/E from Sep 30, 2025 to Jun 3, 2026. The TTM LB Pharmaceuticals (LBRX) P/E is -22.21. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of LB Pharmaceuticals (LBRX)

YearP/EChange
2026-22.21-40.72%
2025-37.47N/A

Comparison LB Pharmaceuticals (LBRX) P/E with competitors

LB Pharmaceuticals (LBRX) P/E is -22.21.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.10-100.46%
ENLVEnlivex Therapeutics Ltd0.15-100.68%
FGENFibroGen Inc0.24-101.08%
TRAWTraws Pharma Inc0.47-102.13%
FBIOFortress Biotech Inc0.71-103.18%
CHRSCoherus Biosciences Inc0.98-104.40%
ORMPOramed Pharmaceuticals Inc1.47-106.63%
AGENAgenus Inc2.05-109.22%
VIVSVivoSim Labs Inc2.54-111.42%
INVAInnoviva Inc3.19-114.36%
CRMDCorMedix Inc3.65-116.41%
ABEOAbeona Therapeutics Inc4.20-118.93%
VXRTVaxart Inc4.26-119.19%
CVACCureVac N.V.4.45-120.02%
SRPTSarepta Therapeutics Inc4.62-120.82%
GLPGGalapagos NV4.86-121.88%
RIGLRigel Pharmaceuticals4.92-122.15%
ZVRAZevra Therapeutics Inc4.97-122.39%
ABUSArbutus Biopharma Corp5.69-125.64%
CGENCompugen Ltd7.38-133.25%
AUPHAurinia Pharmaceuticals Inc9.25-141.65%
ACADAcadia Pharmaceuticals Inc9.59-143.17%
OMEROmeros Corporation9.88-144.50%
PLXProtalix BioTherapeutics Inc9.91-144.61%
SPROSpero Therapeutics Inc10.73-148.33%
ADMAAdma Biologics Inc11.33-151.01%
SVASinovac Biotech Ltd11.44-151.49%
TBPHTheravance Biopharma Inc11.78-153.02%
HRMYHarmony Biosciences Holdings Inc12.18-154.84%
TGTXTG Therapeutics Inc13.18-159.34%
INCYIncyte Corp13.38-160.25%
SABSSAB Biotherapeutics Inc14.06-163.29%
XOMAXOMA Corp14.95-167.29%
REGNRegeneron Pharmaceuticals Inc14.98-167.45%
PBYIPuma Biotechnology Inc15.05-167.76%
EXELExelixis Inc15.79-171.11%
NAGENiagen Bioscience Inc16.35-173.64%
CPRXCatalyst Pharmaceuticals Inc17.34-178.09%
MDXGMimedx Group Inc17.38-178.23%
ARGXArgen X SE23.07-203.88%
HALOHalozyme Therapeutics Inc23.20-204.46%
XOMAOXOMA Corp25.34-214.11%
VRTXVertex Pharmaceuticals Inc25.66-215.51%
XOMAPXOMA Corp25.67-215.58%
CTMXCytomX Therapeutics Inc25.70-215.70%
ASNDAscendis Pharma A/S26.35-218.66%
RPRXRoyalty Pharma plc - Class A27.50-223.80%
SLNOSoleno Therapeutics Inc29.02-230.64%
LGNDLigand Pharmaceuticals Inc - Class B30.19-235.91%
BMRNBiomarin Pharmaceutical Inc37.51-268.87%
APLSApellis Pharmaceuticals Inc39.02-275.69%
KRYSKrystal Biotech Inc39.70-278.73%
GMABGenmab40.20-281.01%
ONCBeiGene Ltd67.03-401.78%
TECHBio-Techne Corp68.59-408.84%
VCELVericel Corp80.63-463.03%
PHARPharming Group N.V.87.74-495.04%
ALNYAlnylam Pharmaceuticals Inc124.93-662.50%
TLXTelix Pharmaceuticals Ltd139.89-729.85%
CORTCorcept Therapeutics Inc158.39-813.13%